Page 78 - MemoriaCIBER2019-ENG

78
CIBER Annual report 2019
• Nupr1 inhibition for treating cancer. Fecha: 31/05/2019.
• Compounds for the treatment of diseases caused by Helicobacter.
• Derivados de 4-fenildihidropiridina para el tratamiento y/o prevención de una infección o enfermedad causada por Helicobacter.
Patents applied for
• NUPR1 Inhibition for Treating Cancer.
• Derivados de ácido ursodecoxicólico para el tratamiento de enfermedades hepáticas poliquísticas.
• Treatment of fibrosis and inhibition of fibrosis in non-alcoholic fatty liver disease patients.
• Methods for diagnosing and treating acute or chronic liver, kidney or lung disease.
• Method of treating colorectal cancer. Fecha:28/06/2018.
• Method of treating advanced colorectal adenoma.
• Human Porphobilinogen Deaminase Derived Proteins And Polynucleotides And Uses Thereof.
Clinical guidelines
• Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus infection in chronic kidney disease: Synop- sis of the kidney disease: Improving global outcomes 2018 clinical practice guideline.
• Document de posicionament: Vies Clíniques Malalties Hepàtiques.
• Participation as an expert in the Darvadstrocel Evaluation report indicated for the treatment of complex perianal
fistulas in patients with Crohn’s disease.
• International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Sym-
posium on Diverticular Disease.
• Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on pouch- itis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.
• Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH.
• Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
• Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care.
• Consensus document for the evaluation of donors with positive hepatitis c virus serology.
• Functional Constipation Guidelines Working Group. European Society of Neurogastroenterology and motility guidelines on functional constipation in adults.